endometrioid

en·do·me·tri·oid

(en'dō-mē'trē-oyd),
Microscopically resembling endometrial tissue.

endometrioid

/en·do·me·tri·oid/ (-me´tre-oid) resembling endometrium.

en·do·me·tri·oid

(en'dō-mē'trē-oyd)
Microscopically resembling endometrial tissue.
References in periodicals archive ?
The five day educational program, "Seminars in Pathology," will focus on topics such as Gastrointestinal Pathology, Endometrioid Carcinoma, Pancreatico-Biliary Disease, Leukemia Classification from WHO, and Atypical Melanocytic Proliferations.
Investigation into various histological subtypes of EOC tumors shows that while the most common histology carries the highest mutation rates of both BRCA1/2, 11% and 6%, respectively; the much rarer subtypes including carcinosarcoma, clear cell and endometrioid subtypes also showed BRCA1/2 mutations at frequencies ranging from 2-6%.
Based on histopathological, immunohistochemical, and molecular genetic analysis, the heterogeneity of EOCs can be further categorized into serous, clear cell, endometrioid, and mucinous types (Lengyel 2010).
Scientists at The University of Texas MD Anderson Cancer Center, Houston, have identified genetic mutations in endometrioid endometrial carcinoma (EEC), the most common form of this cancer of the uterine lining.
Researchers found that hormone replacement therapy increases the risk for only two of the most common types of ovarian cancer --serous and endometrioid ovarian cancers.
Current, short-term use of hormone therapy led to a 43% increase in risk of serous and endometrioid ovarian cancers, according to a large meta-analysis reported online in the Lancet.
Current, short-term use of hormone replacement therapy led to a 43% increase in risk of serous and endometrioid ovarian cancers, according to a large meta-analysis reported online in the Lancet.
Whilst these risk factors have been mostly associated with type I-oestrogen dependent endometrioid tumours, the relationship with type II endometrial cancers remain less clear.
Ovarian neoplasms Surface Origin epithelium Germ cells Frequency 65 - 70% 15 - 20% % of malignant 90% 3 - 5 % Age 20+ 0 - 25+ Types Serous Teratoma Mucinous Dysgerminoma Endometrioid Endodermal sinus Clear Cell Choriocarcinoma Brenner Origin Parenchyma (sex cord-stroma) Metastases Frequency 5 - 10% 5% % of malignant 2 - 3% 5% Age All Variable Types Fibroma Granulosa-theca cell tumor Sertoli-Leydig cell tumor Cystadenofibroma Adapted from: Robbins and Cotran; Pathologic Basis of Disease, 7th Ed Copyright [C] 2005 Elsevier Junqueira and Carneiro; Basic Histology, 11th Ed Copyright [C] 2005 McGraw-Hill Antonio Westphalen, M.
Call-Exner-like areas can be seen in other tumours such as endometrioid carcinoma of the ovary, but in this case the tumour may contain mucin, which is not a feature of GCTs.
The majority of tumors had an endometrioid histology, either pure or mixed, and 14% of the LS patients had nonendometrioid tumors (3 patients with clear cell carcinoma, 3 with uterine papillary serous carcinomas with a clear cell component, and 1 with malignant mixed Mullerian tumor), all of which had MSH2 mutations.
Type I consists of endometrioid carcinoma (EMC) and its histologic variants; type II endometrial cancer includes serous carcinoma, clear cell carcinoma, and carcinosarcoma.